A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware(University of Minnesota Medical Center), Kathy Huppler Hullsiek(University of Minnesota), Nicole Engen(Fairview Health Services), Lauren J MacKenzie(Fairview Health Services), Melanie R. Nicol(University of Minnesota), Matthew F Pullen(Fairview Health Services), Derek LaBar(Fairview Health Services), Glen Drobot(Fairview Health Services), Matthew P. Cheng(McGill University Health Centre), Sylvain Lother(Fairview Health Services), Emily G. McDonald(McGill University), Ryan Zarychanski(CancerCare Manitoba), Lauren E. Kelly(Fairview Health Services), Alanna A Nascene(Fairview Health Services), Elizabeth C Okafor(Fairview Health Services), Todd C. Lee(McGill University Health Centre), Nicole Marten(Fairview Health Services), Sarah M Lofgren(Fairview Health Services), Katelyn A Pastick(Fairview Health Services), Radha Rajasingham(University of Minnesota System), Caleb P Skipper(University of Minnesota Medical Center), Ananta Bangdiwala(RTI International), Ilan S. Schwartz(Fairview Health Services), Mahsa Abassi(University of Minnesota Medical Center)
Cited by 1,406
Related Papers
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*
|Critical Care Medicine|2010|463
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2
|JAMA Internal Medicine|2021|327